Top Story

FDA accepts Genentech’s drug applications for Xofluza in children

March 27, 2020
In the Journals

Universal flu vaccine shows promise in phase 2b trial

March 10, 2020
A single dose of a universal influenza vaccine, adjuvanted FLU-v, may provide prolonged protection against multiple strains of the influenza virus, according to results…
In the JournalsPerspective

Flu vaccine 45% effective in US, 55% effective in children, early estimates show

February 20, 2020
The 2019-2020 influenza vaccine has been 45% effective overall in the United States this season and 55% effective in children, according to preliminary estimates…
FDA NewsPerspective

FDA approves pandemic H5N1 flu vaccine Audenz

February 3, 2020
The FDA announced the approval of a vaccine to protect against pandemic influenza A(H5N1). Audenz (Seqirus) is the first-ever adjuvanted, cell-based vaccine designed to…
More Headlines »
Special Issue Article

Infestations, Bites, and Insect Repellents

Pediatric Annals, March 2020, Volume 49 Issue 3
Infestations and arthropod bite reactions in children are common reasons for presentation to pediatric health care…
More »

Influenza: Addressing the Burden through New Therapeutic Options

This activity is supported by an educational grant from Genentech, Inc.

More »
Meeting News

VIDEO: ‘Excited about developments in influenza vaccine’

November 19, 2018
More »